|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001424 |
Purpose
Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.
| Condition |
|---|
|
Acquired Immunodeficiency Syndrome Cancer HIV Infections Leukemia Lymphoma |
| Study Type: | Observational |
| Official Title: | Evaluation and Natural History of Children With Cancer and AIDS |
| Estimated Enrollment: | 110 |
| Study Start Date: | November 1994 |
| Estimated Study Completion Date: | August 2000 |
This protocol will enable the Pediatric Branch to follow selected children with cancer or HIV infection who are not immediately eligible for protocol enrollment but who are likely, within the next year, to become candidates for protocol entry. It will also enable the Pediatric Branch to follow children who present with either clinical findings that constitute important educational experiences for the NCI trainees or who have unique or unusual medical problems that are likely to benefit from the research expertise of the NCI.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Children with cancer (or a precancer syndrome) or HIV infection, between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol.
Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease.
Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol.
No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.
Contacts and Locations More Information
| Study ID Numbers: | 950025, 95-C-0025 |
| Study First Received: | November 3, 1999 |
| Last Updated: | March 3, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001424 |
| Health Authority: | United States: Federal Government |
|
AIDS Children Human Immunodeficiency Virus |
|
Virus Diseases Lymphatic Diseases Leukemia Sexually Transmitted Diseases, Viral Immunoproliferative Disorders HIV Infections |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Lymphoproliferative Disorders Retroviridae Infections Lymphoma Immunologic Deficiency Syndromes |
|
Neoplasms RNA Virus Infections Pathologic Processes Disease Neoplasms by Histologic Type |
Slow Virus Diseases Immune System Diseases Syndrome Lentivirus Infections Infection |
